Arnhold LLC’s Bristol-Myers Squibb Co Position
Does Arnhold LLC own Bristol-Myers Squibb Co (BMY)? Yes — 391.0K shares worth $24M (+1.74% of its 13F portfolio) as of Q1 2026.
Position Value
$24M
Q1 2026
Shares
391.0K
% of Portfolio
+1.74%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 391.0K | $24M | +1.74% |
| Q4 2025 | 391.0K | $21M | +1.60% |
| Q3 2025 | 391.0K | $18M | +1.47% |
| Q2 2025 | 394.0K | $18M | +1.66% |
| Q1 2025 | 394.0K | $24M | +2.43% |
| Q4 2024 | 435.3K | $25M | +2.43% |
| Q3 2024 | 471.9K | $24M | +2.37% |
| Q2 2024 | 502.8K | $21M | +2.20% |
| Q1 2024 | 356.7K | $19M | +2.05% |
| Q4 2023 | 319.8K | $16M | +1.83% |
| Q3 2023 | 255.3K | $15M | +1.77% |
| Q2 2023 | 231.7K | $15M | +1.68% |
| Q1 2023 | 233.7K | $16M | +1.84% |
| Q4 2022 | 229.1K | $16M | +2.02% |
| Q3 2022 | 238.9K | $17M | +2.28% |
| Q2 2022 | 238.9K | $18M | +2.20% |
| Q1 2022 | 309.1K | $23M | +2.54% |
| Q4 2021 | 437.7K | $27M | +3.09% |
| Q3 2021 | 310.2K | $18M | +2.12% |
| Q2 2021 | 305.6K | $20M | +2.31% |
| Q1 2021 | 306.1K | $19M | +2.32% |
| Q4 2020 | 306.0K | $19M | +2.46% |
| Q3 2020 | 306.1K | $18M | +2.73% |
| Q2 2020 | 306.1K | $18M | +2.86% |
| Q1 2020 | 262.6K | $15M | +2.70% |
| Q4 2019 | 239.1K | $15M | +2.42% |
| Q3 2019 | 346.3K | $18M | +2.98% |
| Q2 2019 | 328.7K | $15M | +2.61% |
| Q1 2019 | 274.4K | $13M | +2.36% |
| Q4 2018 | 211.1K | $11M | +2.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Arnhold LLC’s full portfolio or all institutional holders of BMY.